Trial Review

Did you know?

The ANZCTR now automatically displays published trial results and simplifies the addition of trial documents such as unpublished protocols and statistical analysis plans.

These enhancements will offer a more comprehensive view of trials, regardless of whether their results are positive, negative, or inconclusive.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12623000842662
Ethics application status
Approved
Date submitted
20/07/2023
Date registered
4/08/2023
Date last updated
4/08/2023
Date data sharing statement initially provided
4/08/2023
Type of registration
Prospectively registered

Titles & IDs
Public title
Financial incentives for smoking cessation: qualitative evaluation of the Incentive to Quit (I2Q) pilot across Northern Adelaide Local Health Networks
Scientific title
Financial incentives for smoking cessation: qualitative evaluation of the Incentive to Quit (I2Q) pilot across Northern Adelaide Local Health Networks
Secondary ID [1] 310087 0
Nil
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
smoking 330640 0
Condition category
Condition code
Public Health 327464 327464 0 0
Health promotion/education

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
This is a qualitative study, seeking to explore the acceptability of the I2Q program by relevant stakeholders.

The Incentive to Quit (I2Q) pilot is a smoking cessation intervention running throughout 2023; training health professionals on delivering brief smoking cessation advice, providing smokers/vapers willing to make a genuine quit attempt with financial incentives, use of the Quitline counselling service, and pocket-sized resources with content tailored to help smokers/vapers make a quit attempt or support successful quitters at different stages of their journey. The program follows up with participants at 3 and 6-months following baseline enrolment.

An evaluation of the I2Q intervention will be undertaken via one-on-one interviews with a subset of health professionals and participants (smokers/vapers) of the I2Q program at any time throughout the program period (before, during, and after participation), as well as key stakeholders who may have relevant insight on how to improve the I2Q program, to identify barriers and facilitators to the program's future success for upscale and extended roll-out.

Interviews will be approximately 45 minutes in length and will be facilitated by a member of the Houd Research Group team. Participant interviews will be guided by a semi-structured moderator guide and will include a questionnaire using 7-point Likert scales for attitudes, perceptions, knowledge and behaviours for data triangulation purposes.
Intervention code [1] 326559 0
Not applicable
Comparator / control treatment
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 335416 0
Acceptability of the I2Q program by health professionals via one-on-one interviews
Timepoint [1] 335416 0
At once-off interviews, conducted at any time during the study period; including before, during, or after participation in the program.
Primary outcome [2] 335496 0
Acceptability of the I2Q program with I2Q participants via one-on-one interviews
Timepoint [2] 335496 0
At once-off interviews, conducted at any time during the study period; including before, during, or after participation in the program.
Primary outcome [3] 335497 0
Acceptability of the I2Q program with key community stakeholders via one-on-one interviews
Timepoint [3] 335497 0
At once-off interviews, conducted at any time during the study period.
Secondary outcome [1] 424458 0
Understanding of the facilitators and barriers to the success and upscale of I2Q via one-on-one interviews with health professionals
Timepoint [1] 424458 0
At once-off interviews, conducted at any time during the study period; including before, during, or after participation in the program.
Secondary outcome [2] 424803 0
Understanding of the facilitators and barriers to the success and upscale of I2Q via one-on-one interviews with I2Q participants
Timepoint [2] 424803 0
At once-off interviews, conducted at any time during the study period; including before, during, or after participation in the program.
Secondary outcome [3] 424804 0
Understanding of the facilitators and barriers to the success and upscale of I2Q via one-on-one interviews with key community stakeholders.
Timepoint [3] 424804 0
At once-off interviews, conducted at any time during the study period.

Eligibility
Key inclusion criteria
Health professionals and smokers/vapers who participated in the I2Q program can both be considered as participants for the qualitative evaluation, in addition to key community stakeholders who may have relevant insight.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Unable to provide informed consent.

Study design
Purpose
Natural history
Duration
Cross-sectional
Selection
Defined population
Timing
Prospective
Statistical methods / analysis
Interview transcripts will be coded in NVivo software through deductive thematic analysis by two independent coders, using the COM-B (Capability, Opportunity, Motivation, Behaviour) framework. This model categorises an individual’s behaviours relative to capability, opportunity and motivation to engage in the intervention.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
28/08/2023
Actual
Date of last participant enrolment
Anticipated
26/08/2024
Actual
Date of last data collection
Anticipated
26/08/2024
Actual
Sample size
Target
30
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
SA
Recruitment hospital [1] 25218 0
Lyell McEwin Hospital - Elizabeth Vale
Recruitment hospital [2] 25219 0
Modbury Hospital - Modbury
Recruitment postcode(s) [1] 40889 0
5112 - Elizabeth Vale
Recruitment postcode(s) [2] 40890 0
5092 - Modbury

Funding & Sponsors
Funding source category [1] 314250 0
Government body
Name [1] 314250 0
Drug and Alcohol Services South Australia
Country [1] 314250 0
Australia
Primary sponsor type
Other
Name
Houd Research Group
Address
13 Rossall St, Somerton Park, 5044, SA
Country
Australia
Secondary sponsor category [1] 316274 0
None
Name [1] 316274 0
Address [1] 316274 0
Country [1] 316274 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 313367 0
Aboriginal Health Research Ethics Committee
Ethics committee address [1] 313367 0
220 Franklin Street, Adelaide SA 5000
Ethics committee country [1] 313367 0
Australia
Date submitted for ethics approval [1] 313367 0
06/03/2023
Approval date [1] 313367 0
21/04/2023
Ethics approval number [1] 313367 0
04-22-1038
Ethics committee name [2] 313429 0
SA Department for Health and Wellbeing Human Research Ethics Committee
Ethics committee address [2] 313429 0
PO Box 287, Rundle Mall, SA 5000
Ethics committee country [2] 313429 0
Australia
Date submitted for ethics approval [2] 313429 0
24/05/2023
Approval date [2] 313429 0
Ethics approval number [2] 313429 0

Summary
Brief summary
Reducing tobacco usage has been identified as an urgent national health priority, being the leading cause of preventable death and disability in Australia. The Incentive to Quit (I2Q) pilot aims to reduce the harms associated with smoking and vaping by training health professionals on delivering brief smoking cessation advice, providing smokers/vapers willing to make a genuine quit attempt with financial incentives, use of the Quitline counselling service, and pocket-sized resources with content tailored to help smokers/vapers make a quit attempt or support successful quitters at different stages of their journey. An evaluation of the I2Q intervention will be undertaken via one-on-one interviews with a subset of health professionals and participants (smokers/vapers) of the I2Q program throughout the program period to identify how the service can be improved.
Trial website
https://houdresearch.com.au/i2q/
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 127906 0
A/Prof Kristin Carson-Chahhoud
Address 127906 0
Houd Research Group, 13 Rossall St, Somerton Park, 5044, SA
Country 127906 0
Australia
Phone 127906 0
+61 0412 708 879
Fax 127906 0
Email 127906 0
[email protected]
Contact person for public queries
Name 127907 0
Kelsey Sharrad
Address 127907 0
Houd Research Group, 13 Rossall St, Somerton Park, 5044, SA
Country 127907 0
Australia
Phone 127907 0
+61 0412 708 879
Fax 127907 0
Email 127907 0
[email protected]
Contact person for scientific queries
Name 127908 0
Kelsey Sharrad
Address 127908 0
Houd Research Group, 13 Rossall St, Somerton Park, 5044, SA
Country 127908 0
Australia
Phone 127908 0
+61 0412 708 879
Fax 127908 0
Email 127908 0
[email protected]

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.